ראשי » מאמר » Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial

Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial

תאריך: 22/09/2016

Peter Bader, Hermann Kreyenberg, Arend von Stackelberg, Cornelia Eckert, Emilia Salzmann-Manrique, Roland Meisel, Ulrike Poetschger, Daniel Stachel, Martin Schrappe, Julia Alten, Andre Schrauder, Ansgar Schulz, Peter Lang, Ingo Müller, Michael H. Albert, Andre M. Willasch, Thomas E. Klingebiel, and Christina Peters

DOI: 10.1200/JCO.2014.58.4631 Journal of Clinical Oncology 33, no. 11 (April 2015) 1275-1284.

https://ascopubs.org/doi/10.1200/JCO.2014.58.4631

Published online September 22, 2016.

נותנות החסות לאיגוד:

האיגוד הישראלי להמטולוגיה ולאונקולוגיה ילדים